Currently Open Funding Opportunity Announcements Relevant to Healthcare Delivery Research

This page includes currently open Funding Opportunity Announcements (FOAs) sponsored or co-sponsored by HDRP; other FOAs relevant to HDRP; and NIH and NCI Parent and Omnibus FOAs for investigator-initiated research. Descriptions of the most commonly used grant mechanisms can be found on the NIH Grants & Funding pagesExternal Web Site Policy. If you have questions about a grant application, please contact the NCI Program Director listed on the FOA.

FOAs Sponsored or Co-Sponsored by HDRP

Announcement Title Announcement Number
(Mechanism)
Expiration Date Program Contact
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PA-18-137 (R01 Clinical Trial Optional)External Web Site Policy
PA-18-155 (R21 Clinical Trial Optional)External Web Site Policy
January 8, 2019 Ashley Wilder Smith
240-276-7621
smithas@mail.nih.gov
Examination of Survivorship Care Planning Efficacy and Impact PA-18-002 (R01)External Web Site Policy
PA-18-012 (R21)External Web Site Policy
January 8, 2019 Janet de Moor
240-276-6806
demoorjs@main.nih.gov
Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required) RFA-CA-19-017External Web Site Policy
January 10, 2019 Erica S. Breslau
Telephone: 240-276-6773
Email: breslaue@mail.nih.gov

Nonniekaye Shelburne
Telephone: 240-276-6897
Email: nshelburne@mail.nih.gov
Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS, Second Wave) RFA-CA-19-018 (UG3/UH3 Clinical Trial Required)External Web Site Policy
February 12, 2019 Sarah Kobrin, Ph.D.
240-276-6931
sarah.kobrin@nih.gov
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization PAR-18-246External Web Site Policy (R01 Clinical Trial Optional)
PAR-18-247External Web Site Policy (R21 Clinical Trial Optional)
April 12, 2019 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov
Surgical Disparities Research PAR-16-391 (R01)External Web Site Policy
PAR-16-392 (R21)External Web Site Policy
June 8, 2019 Brenda A. Adjei
240-276-6185
adjeiba@mail.nih.gov
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-18-008 (R01 Clinical Trial Optional)External Web Site Policy
PAR-16-337 (R03)External Web Site Policy
PAR-18-019 (R21 Clinical Trial Optional)External Web Site Policy
July 6, 2019 (R01)
July 17, 2019 (R03 and R21)
Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies PAR-16-368 (R33)External Web Site Policy September 8, 2019 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Research Infrastructure Development for Interdisciplinary Aging Studies PAR-16-367 (R21)External Web Site Policy September 8, 2019 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Methodology and Measurement in the Behavioral and Social Sciences PAR-18-352 (R01 Clinical Trial Optional)External Web Site Policy
PAR-18-378 (R21 Clinical Trial Optional)External Web Site Policy
September 8, 2019 Sandra Mitchell
240-276-6929
mitchellsa@cc.nih.gov
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults PA-18-005 (R01 Clinical Trial Optional)External Web Site Policy
PA-18-015 (R21 Clinical Trial Optional)External Web Site Policy
January 8, 2020 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers PA-18-149 (R01 Clinical Trial Optional)External Web Site Policy
PA-18-167 (R21 Clinical Trial Optional)External Web Site Policy
January 8, 2020 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-18-004 (R01 Clinical Trial Optional)External Web Site Policy
PA-18-014 (R21 Clinical Trial Optional)External Web Site Policy
January 8, 2020 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests PA-17-495 (R01 Clinical Trial Optional)External Web Site Policy
January 8, 2021 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-492External Web Site Policy (R21 Clinical Trial Optional)
PA-18-493External Web Site Policy (R01 Clinical Trial Optional)
May 8, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) PA-18-932External Web Site Policy January 08, 2022 Erica Breslau
240-276-6773
breslaue@mail.nih.gov

Other FOAs Relevant to HDRP

Announcement Title Announcement Number
(Mechanism)
Expiration Date Program Contact
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (Domestic and International Funding Opportunity) PAR-18-007 (R01 Clinical Trial Optional)External Web Site Policy
PAR-18-017 (R21 Clinical Trial Optional)External Web Site Policy
PAR-16-237 (R03)External Web Site Policy
January 8, 2019 Nonniekaye Shelburne
240-276-6897
nshelburne@mail.nih.gov
Dissemination and Implementation Research in Health PAR-16-238 (R01)External Web Site Policy
PAR-16-236 (R21)External Web Site Policy
PAR-16-237 (R03)External Web Site Policy
May 8, 2019 David Chambers
240-276-5090
dchamber@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov

Gila Neta
240-276-6785
netagil@mail.nih.gov
Population Health Interventions: Integrating Individual and Group Level Evidence PA-16-146 (R01)External Web Site Policy
PA-16-147 (R21)External Web Site Policy
May 8, 2019 David Berrigan
240-276-6752
berrigand@mail.nih.gov
Cancer-Related Behavioral Research through Integrating Existing Data PAR-16-256 (R01)External Web Site Policy
PAR-16-255 (R21)External Web Site Policy
June 15, 2019 Rick Moser
240-276-6915
moserr@mail.nih.gov
Addressing Health Disparities through Effective Interventions Among Immigrant Populations PA-18-284 (R01 Clinical Trial Optional)External Web Site Policy
PA-18-285 (R21 Clinical Trial Optional)External Web Site Policy
January 8, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Research to Improve Native American Health (R21 Clinical Trials Optional)
PAR-17-496 (R01)External Web Site Policy

PAR-17-464 (R21)External Web Site Policy
May 15, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov

NIH and NCI Parent and Omnibus FOAs for Investigator-Initiated Research

Announcement Title Announcement Number
(Mechanism)
Expiration Date
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs PA-17-302 (SBIR)External Web Site Policy
PA-17-303 (STTR)External Web Site Policy
May 8, 2019
NCI Small Grants Program for Cancer Research PAR-16-416 (R03)External Web Site Policy May 8, 2019
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-18-484 (R01) External Web Site Policy January 8, 2021
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) PAR-18-559External Web Site Policy January 8, 2021
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) PAR-18-869External Web Site Policy March 9, 2021

Visit https://grants.nih.gov/grants/guide/parent_announcements.htmExternal Web Site Policy for a full list of all NIH parent announcements.